Loss of hMSH2 expression in primary breast cancer with p53 alterations

Ilaria Spagnoletti1, Claudia Pizzi, Annamaria Galietta

  • 1Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università di Napoli 'Federico II', 80131 Napoli, Italy.

Oncology Reports
|March 11, 2004
PubMed

Insights

DNA mismatch repair gene hMSH2 expression is underexplored in breast cancer. Loss of hMSH2 correlated with p53 and steroidal receptor expression but not microsatellite instability.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • DNA mismatch repair (MRG) gene inactivation is a pathway for cancer development, causing genetic instability.
  • Germline mutations in MRG genes are linked to hereditary non-polyposis colorectal cancer (HNPCC) and microsatellite instability (MSI).
  • The expression of MRG genes in primary breast cancer remains largely uninvestigated.

Purpose of the Study:

  • To investigate the relationship between hMSH2 expression and clinicopathological/biological characteristics in primary invasive breast cancers.
  • To explore the association between hMSH2 expression and microsatellite instability (MSI) in breast tumors.
  • To understand the role of hMSH2 in breast cancer oncogenesis.

Main Methods:

  • Analysis of hMSH2 expression in 44 primary invasive breast cancer tissues.
  • Correlation of hMSH2 expression with clinicopathological features, including p53, p185, and steroidal receptor expression.
  • Assessment of hMSH2 expression in relation to MSI at 9 dinucleotide loci in 30 cases.

Main Results:

  • hMSH2 was not expressed in 25% (11/44) of the breast cancer cases.
  • Tumors lacking hMSH2 expression showed a higher frequency of p53 alterations (p=0.05) and trends towards increased p185 and steroidal receptor expression (p=0.07).
  • No significant correlation was found between hMSH2 expression and MSI status in the analyzed cases.

Conclusions:

  • hMSH2 deficiency in breast cancer is associated with specific molecular alterations (p53, p185, steroidal receptors), suggesting potential common pathways.
  • The lack of correlation between hMSH2 and MSI indicates that breast cancer progression may involve different oncogenetic mechanisms than HNPCC.
  • Further research is needed to elucidate the precise role of hMSH2 in breast cancer development and progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...